130 related articles for article (PubMed ID: 6148534)
1. A reappraisal of rheumatic diseases and immunogenetics.
Brewerton DA
Lancet; 1984 Oct; 2(8406):799-802. PubMed ID: 6148534
[No Abstract] [Full Text] [Related]
2. [Immunogenetics: clinical and population aspects. HLA system: clinical correlations. I. (2d of 5 parts)].
Contu L; Carcassi C; la Nasa G
Ann Ital Med Int; 1991; 6(1 Pt 1):17-55. PubMed ID: 1892725
[No Abstract] [Full Text] [Related]
3. Immunogenetics of rheumatic diseases.
Aho K
Scand J Rheumatol Suppl; 1980; 38():17-23. PubMed ID: 6782664
[No Abstract] [Full Text] [Related]
4. [HLA antigens in rheumatology].
Sadowska-Wróblewska M
Reumatologia; 1983; 21(3-4):285-8. PubMed ID: 6424202
[No Abstract] [Full Text] [Related]
5. [The significance of immunogenetics in the study of rheumatoid diseases].
Dostál C
Cas Lek Cesk; 1984 Jun; 123(24):727-30. PubMed ID: 6331884
[No Abstract] [Full Text] [Related]
6. [HLA class I antigens: from molecular-genetic analysis to their role in the etiopathogenesis of various rheumatic diseases].
Segal VE
Mol Gen Mikrobiol Virusol; 1987 Oct; (10):3-14. PubMed ID: 3323898
[TBL] [Abstract][Full Text] [Related]
7. HLA in rheumatology.
Svejgaard A; Friis J; Morling N; Ryder LP
J Rheumatol; 1981; 8(4):541-6. PubMed ID: 6975375
[No Abstract] [Full Text] [Related]
8. Genetic markers in rheumatological diseases.
Laurent MR; Welsh KI
J Immunogenet; 1983 Aug; 10(4):275-91. PubMed ID: 6352822
[No Abstract] [Full Text] [Related]
9. [Immunogenetic risk factors in rheumatic diseases].
Matej N
Klin Med (Mosk); 1989 Jul; 67(7):112-6. PubMed ID: 2811199
[No Abstract] [Full Text] [Related]
10. Histocompatibility antigens and rheumatic diseases.
Dodd MJ; Dick WC
S Afr Med J; 1982 Mar; 61(12):425-8. PubMed ID: 6977877
[TBL] [Abstract][Full Text] [Related]
11. [Histocompatibility antigens and rheumatic disorders (author's transl)].
Arriagada M; Arinoviche R; Galdámez M
Rev Med Chil; 1978 Nov; 106(11):903-9. PubMed ID: 107553
[No Abstract] [Full Text] [Related]
12. The immunogenetics of rheumatic diseases.
McDermott M; McDevitt H
Bull Rheum Dis; 1988; 38(1):1-10. PubMed ID: 3064846
[No Abstract] [Full Text] [Related]
13. Pacemaker treated women with heart block have no increase in the frequency of HLA-B27 and associated rheumatic disorders in contrast to men--a sex linked difference in disease susceptibility.
Bergfeldt L; Möller E
J Rheumatol; 1986 Oct; 13(5):941-3. PubMed ID: 3493346
[TBL] [Abstract][Full Text] [Related]
14. Genes for immunoglobulin heavy chains and for alpha 1-antitrypsin are localized to specific regions of chromosome 14q.
Cox DW; Markovic VD; Teshima IE
Nature; 1982 Jun; 297(5865):428-30. PubMed ID: 6804874
[No Abstract] [Full Text] [Related]
15. [HLA B27-associated rheumatic diseases from the clinical viewpoint].
Mathies H
Klin Monbl Augenheilkd; 1985 Dec; 187(6):493-4. PubMed ID: 3879317
[TBL] [Abstract][Full Text] [Related]
16. [Immunogenetics in the human].
Riethmüller G
Verh Dtsch Ges Inn Med; 1986; 92():106-8. PubMed ID: 3101305
[No Abstract] [Full Text] [Related]
17. [Molecular genetics of the major histocompatibility complex].
Witt M
Postepy Biochem; 1985; 31(2):323-36. PubMed ID: 3938015
[No Abstract] [Full Text] [Related]
18. [Diagnostic value of the HLA phenotype in inflammatory rheumatic diseases].
Saraux A; Guedes C; Allain J; Devauchelle V; Valls I; Baron D; Youinou P; Le Goff P
Presse Med; 1997 Jun; 26(22):1040-4. PubMed ID: 9246112
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of the human HLA-A2 or HLA-B7 heavy chain gene and human beta 2-microglobulin gene in L cells.
Bernabeu C; Maziarz R; Spits H; de Vries J; Burakoff SJ; Terhorst C
J Immunol; 1984 Dec; 133(6):3188-94. PubMed ID: 6436376
[TBL] [Abstract][Full Text] [Related]
20. Rheumatic disorders in a HLA B27 positive population.
Veys EM; Mielants H; Poriau S; Verbruggen G; Van Der Jeught J; Dhondt E; Goethals L
Acta Rhumatol Belg; 1979; 3(2):176-90. PubMed ID: 317555
[No Abstract] [Full Text] [Related]
[Next] [New Search]